Building & Investing in Recurring Revenue, Highly Scalable Businesses
Partner Underdog Labs Seed Fund
Entrepreneur, adventurer.
Linked In Description:
Serial entrepreneur with interest scalable businesses with recurring revenue models. Also interested in businesses with social mission. Specialties: Internet, startups, strategic partnerships, business development, business models, consumer membership models, recurring revenue models
Zach Weinberg
Investing in Software (Web Marketplace Saas..) &b...
How to connect with Angel Investors in the Pharmaceutical industry?
In the Pharmaceutical & Medicine industry, angel investors such as Esther Dyson, Vinod Khosla, and Steve Jurvetson are prominent figures. These investors focus on startups offering innovative solutions in drug development, biotechnology, and medical research. Esther Dyson, an entrepreneur and investor, invests in pharmaceutical startups that leverage technology to advance medical research and improve patient outcomes. Vinod Khosla, founder of Khosla Ventures, looks for companies that provide groundbreaking pharmaceutical solutions and therapies. Steve Jurvetson, a co-founder of Future Ventures, seeks out startups with strong scientific foundations and significant market potential. To connect with these investors, attend pharmaceutical conferences, biotech expos, and networking events such as BIO International Convention, JP Morgan Healthcare Conference, and CPhI Worldwide. Utilize platforms like AngelList and LinkedIn to identify and reach out to potential investors. When pitching, emphasize how your pharmaceutical solution addresses key challenges, such as improving drug efficacy, enhancing patient care, or advancing medical research. Highlight any traction you’ve gained, such as partnerships with research institutions, successful clinical trials, or regulatory approvals. Building relationships through initial informal meetings or discussions at industry panels can help establish trust with these investors. Demonstrating the impact of your technology through case studies or clinical results can also add credibility. Personalize your outreach by referencing the investor’s previous investments and explaining how your venture aligns with their interests. Demonstrating a sustainable business model with clear revenue streams, such as drug sales, licensing, or research grants, will further strengthen your pitch. Leveraging endorsements or case studies from pharmaceutical experts can also enhance your credibility.
Case Studies: Successful Funding Rounds with Angel Investors on Angels Partners
Exotic Orange & Angels Partners: Turning Financial Simplicity Into Investment Success
